Nogapendekin alfa inbakicept with BCG for non-muscle-invasive bladder cancer with carcinoma in situ that is unresponsive to BCG (terminated evaluation)

  • Technology appraisal
  • TA1163
  • Published: 

History

Documents created during the development process.

Committee meetings

  • Committee meeting

Invitation to participate

Notes

Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators: 6582